Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While…
In Association With ILC Dover
Powder Handling
Chemical synthesis: containment challenges for HPAPI handling
How API CMOs can improve containment capabilities without facility acquisition
The future of the gene therapy market: driving innovations in biotherapeutics
Protecting the supply chain: Why biopharma needs integrated workflows
Powered air-purifying respirators: a necessity for small molecule API manufacturing
How isolators can cut cleaning measures with contamination-free disposal
Maximise profits while minimising product loss with 3D powder handling
